BAM
CDAK

Belpointe Asset Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Belpointe Asset Management’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,506
Closed -$996 – 3899
2022
Q4 		$996 Buy
+2,506
New +$996 ﹤0.01% 3438